Latest filing published 30 Jun 2017 for Aptose Biosciences Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Gregory Kwok Lee Chow: trading record in brief
Gregory Kwok Lee Chow appears in our data through filings on Aptose Biosciences Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 26 June 2017 and the latest from 28 June 2017.
Both buying and selling appear: 1 purchase worth €7,621, against 1 sale worth €15k. Sales outweigh purchases by €7,729. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise.
The record was last updated on 30 June 2017 with an option exercise in Aptose Biosciences Inc. The latest purchase dates back some time: it was published 3,419 days ago, on 30 June 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gregory Kwok Lee Chow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 sharesCommon SharesTSXSEDI:3028315
- 18,986 shares@ CA$1.20Common SharesTSXSEDI:3028346
- 10,000 shares@ CA$1.13Common SharesTSXSEDI:3028372Canonical exit: 24 Sept 2017 (T+90)
3 of 3 declarations